Literature DB >> 21904637

Brain microvasculature and hypoxia-related proteins in Alzheimer's disease.

Paula Grammas1, Debjani Tripathy, Alma Sanchez, Xiangling Yin, Jinhua Luo.   

Abstract

Alzheimer's disease (AD) is a progressive, neurodegenerative disease of increasing incidence. The pathologic processes that underlie this disorder are incompletely understood, however, hypoperfusion/hypoxia is thought to contribute to disease pathogenesis. Hypoxia inducible factor 1-alpha (HIF-1α), a key regulator of cellular responses to hypoxia, is elevated in the microcirculation of AD patients. Cerebral hypoxia is a potent stimulus for vascular activation and angiogenesis. Microvessels isolated from the brains of AD patients express a large number of angiogenic proteins. Despite considerable data in human tissues regarding vascular expression of hypoxia-related angiogenic proteins, there is little information regarding these proteins in the brain vasculature of transgenic AD mice. The objectives of this study were to determine expression of HIF-1α, angiogenic proteins, angiopoietin-2 (Ang-2), and matrix metalloproteinase 2 (MMP2), and survival/apoptotic proteins (Bcl-xL, caspase 3) in the cerebromicrovasculature of AD transgenic mice and to determine the direct effect of hypoxia on cerebral endothelial expression of these proteins in vitro. Cultured brain endothelial cells were subjected to hypoxia for 4-6 h and analyzed by western blot and immunofluorescence. Our results demonstrated that HIF-1α is induced in cultured brain endothelial cells exposed to hypoxia and that expression of Ang-2, MMP2 and caspase 3 was elevated and the anti-apoptotic protein Bcl-xL decreased. Brain sections from AD and control mice showed that HIF-1α, Ang-2, MMP2 and caspase 3 are elevated and Bcl-xL decreased in the microvasculature of AD mice. These data suggest the cerebromicrovasculature is an important target for the effects of hypoxia in the AD brain.

Entities:  

Keywords:  AD mice; Hypoxia; angiogenesis; apoptosis; brain microvessels

Mesh:

Substances:

Year:  2011        PMID: 21904637      PMCID: PMC3160613     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  71 in total

1.  The blood-brain barrier in Alzheimer's disease and normal aging.

Authors:  C L Masters; K Beyreuther
Journal:  Neurobiol Aging       Date:  1988 Jan-Feb       Impact factor: 4.673

2.  Differential degeneration of the cerebral microvasculature in Alzheimer's disease.

Authors:  R N Kalaria; P Hedera
Journal:  Neuroreport       Date:  1995-02-15       Impact factor: 1.837

3.  Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain.

Authors:  R N Kalaria; S U Bhatti; E A Palatinsky; D H Pennington; E R Shelton; H W Chan; G Perry; W D Lust
Journal:  Neuroreport       Date:  1993-02       Impact factor: 1.837

4.  Isolation and characterization of cerebral resistance vessel endothelium in culture.

Authors:  C A Diglio; W Liu; P Grammas; F Giacomelli; J Wiener
Journal:  Tissue Cell       Date:  1993-12       Impact factor: 2.466

5.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.

Authors:  L Buée; P R Hof; C Bouras; A Delacourte; D P Perl; J H Morrison; H M Fillit
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation.

Authors:  Sun-Ryung Lee; Eng H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2004-07       Impact factor: 6.200

7.  Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat.

Authors:  D T Stephenson; K Rash; J A Clemens
Journal:  Brain Res       Date:  1992-10-09       Impact factor: 3.252

8.  Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

Authors:  J C Breitner; K A Welsh; M J Helms; P C Gaskell; B A Gau; A D Roses; M A Pericak-Vance; A M Saunders
Journal:  Neurobiol Aging       Date:  1995 Jul-Aug       Impact factor: 4.673

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.

Authors:  M A Dorheim; W R Tracey; J S Pollock; P Grammas
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

View more
  23 in total

1.  Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.

Authors:  Matej Mihelčić; Goran Šimić; Mirjana Babić Leko; Nada Lavrač; Sašo Džeroski; Tomislav Šmuc
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 2.  Vascular disease and dementias: paradigm shifts to drive research in new directions.

Authors:  Mitchel A Kling; John Q Trojanowski; David A Wolk; Virginia M Y Lee; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

3.  Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues.

Authors:  Sid E O'Bryant; Guanghua Xiao; Fan Zhang; Melissa Edwards; Dwight C German; Xiangling Yin; Tori Como; Joan Reisch; Ryan M Huebinger; Neill Graff-Radford; Dennis Dickson; Robert Barber; James Hall; Padraig O'Suilleabhain; Paula Grammas
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 4.  Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.

Authors:  Jianping Guo; Ji Cheng; Brian J North; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-07-08       Impact factor: 10.680

5.  Exercise training ameliorates cerebrovascular dysfunction in a murine model of Alzheimer's disease: role of the P2Y2 receptor and endoplasmic reticulum stress.

Authors:  Junyoung Hong; Soon-Gook Hong; Jonghae Lee; Joon-Young Park; Jason L Eriksen; Bridgette V Rooney; Yoonjung Park
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

Review 6.  Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.

Authors:  Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

Review 7.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

8.  Investigation of PI3K/PKB/mTOR/S6K1 signaling pathway in relationship of type 2 diabetes and Alzheimer's disease.

Authors:  Yunqing Ma; Dongke Wu; Wei Zhang; Jiankun Liu; Siping Chen; Binghong Hua
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Targeting disease through novel pathways of apoptosis and autophagy.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

10.  Meox2 haploinsufficiency increases neuronal cell loss in a mouse model of Alzheimer's disease.

Authors:  Ileana Soto; Weronika A Grabowska; Kristen D Onos; Leah C Graham; Harriet M Jackson; Stephen N Simeone; Gareth R Howell
Journal:  Neurobiol Aging       Date:  2016-03-02       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.